BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 20.06.2019

Scientific Data and Information About Products Containing Cannabis or Cannabis-Derived Compounds; Extension of Comment Period

The Food and Drug Administration (FDA or we) is extending the comment period for the notice that appeared in the Federal Register of April 3, 2019. The notice announced a public hearing to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds. In addition, it notified the public that FDA was establishing a docket for public comment on this hearing and that the docket would close on July 2, 2019. We are extending the comment period to give interested parties more time to comment.

Source: Federal Register — Food and Drug AdministrationOpen original release →